Author Correction: Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Joanne Verheij added to the LITMUS Consortium Investigators list for the LITMUS Imaging Study of MASLD biomarkers

  • By

  • Michael Pavlides

  • Yasaman Vali

  • Ferenc E. Mózes

  • Kristy Wonders

  • Salma Akhtar

  • Paul D. Hockings

  • Elizabeth Shumbayawonda

  • Kay Pepin

  • Isabel Fernandez-Lizaranzu

  • Diana Julie Leeming

  • Jeremy F. Cobbold

  • Michael E. D. Allison

  • Guruprasad P. Aithal

  • Manuel Romero-Gomez

  • Rocio Aller

  • Juan M. Pericàs

  • Jérôme Boursier

  • Salvatore Petta

  • Jörn M. Schattenberg

  • Mattias Ekstedt

  • Annalisa Berzigotti

  • Hannele Yki-Järvinen

  • Miljen Martic

  • Theresa Tuthill

  • Clifford A. Brass

  • Michael Kalutkiewicz

  • Rajarshi Banerjee

  • Richard L. Ehman

  • Moritz J. Schneider

  • Dina Tiniakos

  • Morten Karsdal

  • Jeremy Magnanensi

  • Céline Fournier-Poizat

  • Vlad Ratziu

  • Carla Yunis

  • Elisabetta Bugianesi

  • Stephen A. Harrison

  • Patrick M. Bossuyt

  • Quentin M. Anstee

  • November 19, 2026

Share

  • 1

    A correction to the LITMUS Imaging Study of MASLD biomarkers was published online on July 24, 2026.

  • 2

    The correction concerns a Nature Medicine article with DOI 10.1038/s41591-026-04496-2.

  • 3

    Joanne Verheij was added to the LITMUS Consortium Investigators list.

  • 4

    Verheij is affiliated with the Department of Pathology at Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, in Amsterdam, The Netherlands.

  • 5

    Verheij’s name was absent from the initially published article and is now included in its HTML and PDF versions.

Original Source(s)

Related Content